Add to Calendar
Lecture Title:
Cell Signaling By Receptor Tyrosine Kinases; From Basic Principles To Cancer And Other Therapies
Synopsis:
Receptor tyrosine kinases (RTK) play important roles in the control of a variety of normal cellular process and in tissue homeostasis. RTKs are also frequently mutated, overexpressed or aberrantly activated in a variety of human cancers providing druggable targets for targeted cancer therapies. Elucidation of the mechanism of RTK activation and their cellular signaling pathways provide valuable insights into the development of new cancer therapeutics.
Brief Bio:
Joseph Schlessinger is the William H. Prusoff Professor at Yale University School of Medicine in the Department of Pharmacology, where he was Chairman from 2001-2022. He is also the founding director of the Cancer Biology Institute at Yale & Chief Scientist of Yale Cancer Center. Dr. Schlessinger has authored or co-authored over 500 scientific papers & articles, founded 6 pharmaceutical companies and brought 4 FDA approved drugs to market.